DEG treatment did not affect the growth of either the human CD19+ CAR T cells or the murine OT1 T cells (Extended Data Fig. 5a,b) or cause any toxicity in the tumour cells themselves (Extended Data Fig. 5c,d). Here, CD19 is linked to neoplasm.